Literature DB >> 1175863

Cardiac changes during 2-deoxy-d-glucose test. A study in patients with selective vagotomy and pyloroplasty.

D Burckhardt, G A Stalder.   

Abstract

2-Deoxy-D-glucose (2-DG), a potent vagal stimulator, is used for testing the completeness of surgical vagotomies. 2-DG has however not yet been employed routinely for the postoperative testing of bagotomized patients because of possible cardiotoxic effects. In a previous study, we have shown the effects of 2-DG on the resting ECG in 48 patients. We did not observe any significant changes besides nonspecific T wave flattening and QT prolongation. The present investigation included 37 additional patients. In 27 patients, a continuous ECG tape recording for detection of arrhythmias was performed and in 10 patients, the systolic time intervals for non-invasive assessment of the myocardial contractility was recorded before and after 2-DG. Serious arrhythmias were not provoked by 2-DG. Premature contractions were, as a whole, not incrased by the drug. 2-DG did not have any cardiodepressive action. On the contrary myocardial contractility evaluated by the systolic time intervals was enhanced.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1175863     DOI: 10.1159/000197647

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  1 in total

1.  Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies.

Authors:  Mark Stein; Hongxia Lin; Chandrika Jeyamohan; Dmitri Dvorzhinski; Murugesan Gounder; Kevin Bray; Simantini Eddy; Susan Goodin; Eileen White; Robert S Dipaola
Journal:  Prostate       Date:  2010-09-15       Impact factor: 4.104

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.